FDA’s Peter Stein And Lessons From Makena: There Are Limits To Regulatory Flexibility

 
• By Sarah Karlin-Smith
Makena - Nguyen and Stein
CDER’s Nguyen and Stein wrap up a persuasive round of ‘cross-examination’ of Covis at Makena hearing • Source: Screenshot of FDA hearing

More from US FDA Performance Tracker

More from Regulatory Trackers